The Synthesis and Bioassay of Novel Pyrroles
新型吡咯类化合物的合成及生物测定
基本信息
- 批准号:8271103
- 负责人:
- 金额:$ 34.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdverse effectsAmidesAreaAttentionBiologicalBiological AssayBiological FactorsBlood VesselsBreast Cancer CellCancer cell lineCarbonCell DeathCell SurvivalCellsChemotherapy-Oncologic ProcedureClinicalColorectal CancerCoupledDataDevelopmentDiseaseDrug resistanceEvaluationExhibitsFundingGoalsGrantHIVHIV Integrase InhibitorsIn VitroIndolesInhibitory Concentration 50LeadMalignant neoplasm of prostateMarinesMelanoma CellMethodologyModelingMolecular ModelsMulti-Drug ResistanceMusPharmaceutical PreparationsPositioning AttributeProcessPropertyProtein Kinase InhibitorsProteinsPyrrolesReactionResearchSaltsSodium ChlorideSourceSpecific qualifier valueStaurosporineStructure-Activity RelationshipSubcategorySystemTopoisomeraseTreatment-Related CancerUnited States National Institutes of HealthWorkXenograft procedureanalogantitumor agentcancer cellchemotherapeutic agentcytotoxiccytotoxicitydrug candidatedrug discoveryexperiencein vitro activityin vivointerestmarine natural productmeetingsmolecular modelingnovelpromoterprotein kinase inhibitortubulin polymerization inhibitor
项目摘要
DESCRIPTION (provided by applicant): This proposal represents a continuation of work initiated under NIH AREA grant CA 67236-04. Natural products of marine origin continue to be a rich source of biologically interesting compounds and pyrrole containing marine natural products in particular have demonstrated activity as anti-tumor agents, multidrug resistant reversal agents, vascular disrupting agents and inhibitors of HIV integrase. These pyrrole containing natural products are usually characterized by highly oxygenated phenyl or heterocyclic groups attached at carbons 3 and 4 of the pyrrole ring system along with carbonyl containing functionality located at carbons 2 and/or 5. The synthetic methodology that we have established and are developing allows for rapid construction of highly substituted and highly functionalized pyrroles. This methodology also allows for great structural diversity for structure activity relationship (SAR) studies, which could lead to chemotherapeutic agents with increased potency and decreased toxic side effects. Work proposed for the new funding cycle will involve applying our synthetic methodology along with some new and complimentary methodology to the synthesis of the marine natural products lycogallic acid, lycogarubin B, lycogarubin C, lynamycin E and related compounds, such as new analogs of JG-03-14. JG-03-14 is an interesting synthetic pyrrole, which has emerged from our research efforts, and has demonstrated in vitro activity (IC50 of 35 nM) against breast cancer cell lines and in vivo activit against a mouse prostate cancer xenograft. JG-03-14 has also been shown to be active against drug resistant breast cancer cell lines, an inhibitor of tubulin polymerization, a vascular disrupting agent and a promoter of autophagic cell death. Our current and evolving synthetic methodologies will allow us to extend our targets to these important bioactive, natural products and new JG-03-14 analogs. All of the target molecules, their precursors and their analogs will be subject to biological evaluation by a team of highly experienced collaborators and such studies will be coupled with molecular modeling by an additional collaborator. Since our project encompasses synthesis, bioassay and molecular modeling driven SAR, we believe that a novel and viable clinical candidate for cancer chemotherapy may well emerge from such studies.
PUBLIC HEALTH RELEVANCE: The development of new and novel chemotherapeutic agents for a particular disease state continues to depend to a significant degree on the discovery of a "lead compound", which can be further developed into a viable drug candidate. Naturally occurring compounds continue to be a major source of "drug leads" and our current proposal seeks to utilize our pyrrole forming reactions to synthesize biologically interesting natural products such as lycogallic acid, lycogarubins B and C, lynamycin E and related compounds. In addition to these natural product targets, we will continue to develop new derivatives of our synthetic pyrrole, JG-03-14, which continues to exhibit promising biological properties. The majority of these natural products, their analogs and precursors along with JG-03-14 analogs will be biologically evaluated and computationally modeled by a team of highly experienced collaborators.
描述(由申请人提供):本提案是NIH AREA资助CA 67236-04下启动的工作的延续。海洋来源的天然产物仍然是生物学上令人感兴趣的化合物的丰富来源,特别是含有吡咯的海洋天然产物已被证明具有作为抗肿瘤剂、多药耐药逆转剂、血管破坏剂和HIV整合酶抑制剂的活性。这些含吡咯的天然产物的特征通常是在吡咯环系统的碳3和4处连接高度氧化的苯基或杂环基团,以及沿着位于碳2和/或5处的含羰基官能团。我们已经建立并正在开发的合成方法允许快速构建高度取代和高度官能化的吡咯。该方法还允许用于结构活性关系(SAR)研究的大的结构多样性,这可能导致具有增加的效力和降低的毒副作用的化学治疗剂。为新的供资周期提出的工作将涉及应用我们的合成方法沿着一些新的补充方法,合成海洋天然产品石蒜酸、石蒜红素B、石蒜红素C、林霉素E和相关化合物,如JG-03-14的新类似物。JG-03-14是一种有趣的合成吡咯,它已经从我们的研究工作中出现,并已证明对乳腺癌细胞系的体外活性(IC 50为35 nM)和对小鼠前列腺癌异种移植物的体内活性。JG-03-14还被证明对耐药乳腺癌细胞系、微管蛋白聚合的抑制剂、血管破坏剂和自噬细胞死亡的促进剂具有活性。我们目前和不断发展的合成方法将使我们能够将目标扩展到这些重要的生物活性天然产物和新的JG-03-14类似物。所有的目标分子,它们的前体和它们的类似物将由一个经验丰富的合作者团队进行生物学评价,这些研究将与另一个合作者的分子建模相结合。由于我们的项目包括合成,生物测定和分子模拟驱动的SAR,我们相信,一个新的和可行的癌症化疗的临床候选人很可能出现从这样的研究。
公共卫生相关性:用于特定疾病状态的新的和新颖的化学治疗剂的开发继续在很大程度上依赖于“先导化合物”的发现,其可以进一步开发成可行的候选药物。天然存在的化合物仍然是“药物先导物”的主要来源,并且我们目前的提议寻求利用我们的吡咯形成反应来合成生物学上感兴趣的天然产物,例如石蒜酸、石蒜红素B和C、林霉素E和相关化合物。除了这些天然产物目标,我们将继续开发我们的合成吡咯JG-03-14的新衍生物,它继续表现出有前途的生物学特性。这些天然产物中的大多数,它们的类似物和前体沿着JG-03-14类似物将由一组经验丰富的合作者进行生物学评价和计算建模。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The application of vinylogous iminium salt derivatives to efficient formal syntheses of the marine akaloids lamellarin G trimethyl ether and ningalin B.
- DOI:10.1016/j.tet.2009.03.085
- 发表时间:2009-05-30
- 期刊:
- 影响因子:2.1
- 作者:Gupton JT;Giglio BC;Eaton JE;Rieck EA;Smith KL;Keough MJ;Barelli PJ;Firich LT;Hempel JE;Smith TM;Kanters RP
- 通讯作者:Kanters RP
Further studies on vinamidinium salt amine exchange reactions, borohydride reductions and subsequent transformations.
- DOI:10.1016/j.tet.2010.08.075
- 发表时间:2010-10-30
- 期刊:
- 影响因子:2.1
- 作者:Gupton JT;Telang N;Jia X;Giglio BC;Eaton JE;Barelli PJ;Hovaizi M;Hall KE;Welden RS;Keough MJ;Worrall EF;Finzel KL;Kluball EJ;Kanters RP;Smith TM;Smith SQ;Nunes SR;Wright MT;Birnstihl JM
- 通讯作者:Birnstihl JM
Effects of a pyrrole-based, microtubule-depolymerizing compound on RAW 264.7 macrophages.
- DOI:10.1016/j.cbi.2016.01.009
- 发表时间:2016-02-25
- 期刊:
- 影响因子:5.1
- 作者:Ciemniecki JA;Lewis CP;Gupton JT;Fischer-Stenger K
- 通讯作者:Fischer-Stenger K
Pyrrole-Based Antitubulin Agents: Two Distinct Binding Modalities are Predicted for C-2 Analogs in the Colchicine Site.
- DOI:10.1021/ml200217u
- 发表时间:2012-01-12
- 期刊:
- 影响因子:4.2
- 作者:Da, Chenxiao;Telang, Nakul;Barelli, Peter;Jia, Xin;Gupton, John T.;Mooberry, Susan L.;Kellogg, Glen E.
- 通讯作者:Kellogg, Glen E.
The application of formyl group activation of bromopyrrole esters to formal syntheses of lycogarubin C, permethyl storniamide A and lamellarin G trimethyl ether.
溴吡咯酯的甲酰基活化在番茄红素C、全甲基斯托尼酰胺A和板层素G三甲醚的形式合成中的应用。
- DOI:10.1016/j.tet.2014.11.035
- 发表时间:2014
- 期刊:
- 影响因子:2.1
- 作者:Gupton,JohnT;Telang,Nakul;Patteson,Jon;Lescalleet,Kristin;Yeudall,Scott;Sobieski,John;Harrison,Andrew;Curry,Will
- 通讯作者:Curry,Will
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN T. GUPTON其他文献
JOHN T. GUPTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN T. GUPTON', 18)}}的其他基金
The Synthesis and Biological Evaluation of Pyrrole Containing Marine Natural Prod
含吡咯海洋天然产物的合成及生物学评价
- 批准号:
7354888 - 财政年份:1996
- 资助金额:
$ 34.86万 - 项目类别:
A Combination Strategy for Pyrrole-Containing Alkaloids
含吡咯生物碱的组合策略
- 批准号:
6848378 - 财政年份:1996
- 资助金额:
$ 34.86万 - 项目类别:
PYRROLE BASED APPROACH TO RIGIDIN AND RELATED ALKALOIDS
基于吡咯的刚性蛋白和相关生物碱的方法
- 批准号:
2110861 - 财政年份:1996
- 资助金额:
$ 34.86万 - 项目类别:
SYNTHESIS AND BIOASSAY OF HIGHLY FUNCTIONALIZED PYRROLES
高功能化吡咯的合成与生物测定
- 批准号:
2183641 - 财政年份:1992
- 资助金额:
$ 34.86万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 34.86万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 34.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 34.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 34.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 34.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 34.86万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 34.86万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 34.86万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 34.86万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 34.86万 - 项目类别:
Studentship














{{item.name}}会员




